1. Reich O, Fritsch H. The developmental origin of cervical and vaginal epithelium and their clinical consequences: a systematic review. J Low Genit Tract Dis. 2014;18(4):358-360.
2. Kranl C, Zelger B, Kofler H, et al. Vulval and vaginal adenosis. Br J Dermatol. 1998;139(1):128-131.
3. Laronda MM, Unno K, Butler LM, et al. The development of cervical and vaginal adenosis as a result of diethylstilbestrol exposure in utero. Differentiation. 2012;84(3):252-260.
4. Larondo M, Unno K, Ishi K, et al. Diethylstilbestrol induces vaginal adenosis by disrupting SMAD/RUNX1-mediated cell fate decision in the Müllerian duct epithelium. Dev Biol. 2013;381(1):5-16.
5. Martin AA, Atkins KA, Lonergan CL, et al. Vaginal adenosis as a dermatologic complaint . J Am Acad Dermatol. 2013;69(2):e92-e93.
6. National Toxicology Program, Department of Health and Human Services. Diethylstilbestrol. Report on Carcinogens. 12th ed. Research Triangle Park: National Toxicology Program, U.S. Department of Health and Human Services. 2011:159-161.
7. Chattopadhyay I, Cruickshan DJ, Packer M. Non diethylstilbestrol induced vaginal adenosis—a case series and review of literature. Eur J Gynaecol Oncol. 2001;22(4):260-262.
8. Cebesoy FB, Kutlar I, Aydin A. Vaginal adenosis successfully treated with simple unipolar cauterization. J Natl Med Assoc. 2007;99(2):166-167.